Have You Optimized Your Market Access Efforts?
Market access has been a hot topic in pharma for several years now. But while most companies have made the leap to putting payers and other market access stakeholders at the forefront of their thinking, have they adapted their internal structures and key capabilities accordingly? Francesca Boggio and Andrea Sobrio report.
